Recce Ltd has released a press release.
Recce Successfully Raises $1.8 million via Placement
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Change of Registry Address: Automic P/L - Sydney Office
- Key Australian Patent for Recces Broad-Spectrum Antibiotics
- Update on Progress of Broad Spectrum Antibiotic RECCE 327
- Update on meeting with US FDA
- Additional AU$861,590 R&D Tax Incentive Rebate Received
Later from Recce Pharmaceuticals
- USA Patent Granted for Recces Antibiotics
- Appointment of Independent Chair and Additional Director
- Appendix 4C and commentary
- Opening R&D Address at World Antibiotic Resistance Congress
- Key Family 2 Patent Granted in Europe for RECCE Antibiotics
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals